Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 7;10(4):664-669.
doi: 10.1002/mdc3.13699. eCollection 2023 Apr.

Detection of ATXN2 Expansions in an Exome Dataset: An Underdiagnosed Cause of Parkinsonism

Affiliations

Detection of ATXN2 Expansions in an Exome Dataset: An Underdiagnosed Cause of Parkinsonism

Fanny Casse et al. Mov Disord Clin Pract. .

Abstract

Background: CAG-repeat expansions in Ataxin 2 (ATXN2) are known to cause spinocerebellar ataxia type 2 (SCA2), but CAA interrupted expansions may also result in autosomal dominant Parkinson's disease (AD PD). However, because of technical limitations, such expansions are not explored in whole exome sequencing (WES) data.

Objectives: To identify ATXN2 expansions using WES data from PD cases.

Methods: We explored WES data from a cohort of 477 index cases with PD using ExpansionHunter (Illumina DRAGEN Bio-IT Platform, San Diego, CA). Putative expansions were confirmed by combining polymerase chain reaction and fragment length analysis followed by sub-cloning and sequencing methods.

Results: Using ExpansionHunter, we identified three patients from two families with AD PD carrying either ATXN2 22/39 or 22/37 repeats, both interrupted by four CAA repeats.

Conclusion: These findings demonstrate the usefulness of WES to detect pathogenic CAG repeat expansions, which were found in 1.7% of AD PD in the ATXN2 gene in our exome dataset.

Keywords: ATXN2 gene; CAA interruption; Parkinson's disease; repeat expansions; whole exome sequencing.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Estimated ATXN2 repeat size using ExpansionHunter according to the enrichment kits used. The solid line delineates the mean ATXN2 CAG‐repeat size to 22, estimated from Caucasian populations; the dashed line indicates the pathological threshold up to 32.
FIG. 2
FIG. 2
Pedigrees of families A and B with autosomal dominant Parkinson's disease (AD PD) and expanded CAG‐repeat alleles in ATXN2. A: Pedigrees of families A and B. Square = male; circles = female; black symbol = affected; white symbol = unaffected; slashed symbol = deceased. Asterisks indicate individuals with genetic testing and arrow, the proband. AO, age at onset. B: Length and structure of the expanded CAG/CAA repeats in ATXN2 for the three carriers. Open circles = CAG; filled circles = CAA interruptions.

References

    1. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5(6):525–535. 10.1016/S1474-4422(06)70471-9. - DOI - PubMed
    1. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M. α‐Synuclein in Lewy bodies. Nature 1997;388(6645):839–840. 10.1038/42166. - DOI - PubMed
    1. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24(2):197–211. 10.1016/s0197-4580(02)00065-9. - DOI - PubMed
    1. Lunati A, Lesage S, Brice A. The genetic landscape of Parkinson's disease. Rev Neurol 2018;174(9):628–643. 10.1016/j.neurol.2018.08.004. - DOI - PubMed
    1. Charles P, Camuzat A, Benammar N, et al. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology 2007;69(21):1970–1975. 10.1212/01.wnl.0000269323.21969.db. - DOI - PubMed